Started in 2022 with mission to make meaningful contribution to science and therapeutics development Maragin operates similar to a university lab and collaborates with other university labs aiming to bridge the gap between scientific discovery and validation of therapeutic approaches. Organization has a goal of 20 academic collaborations 30 programs 50 papers and 5 proof-of-concept validations per year. Once developed and validated the therapeutic programs will graduate and move onto big pharma for further development. There is no venture capital or investor in what Maragin does. Therefore Maragin works on programs based on scientific merits and can take economically risky approaches which are often necessary for ground-breaking discovery and development.